Literature DB >> 20020670

Lessons learned from the development of kinase inhibitors.

Charles L Sawyers1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20020670

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  2 in total

1.  RAS-MAPK signaling influences the efficacy of ALK-targeting agents in lung cancer.

Authors:  Gorjan Hrustanovic; Trever G Bivona
Journal:  Mol Cell Oncol       Date:  2015-10-29

2.  A framework for understanding and targeting residual disease in oncogene-driven solid cancers.

Authors:  Trever G Bivona; Robert C Doebele
Journal:  Nat Med       Date:  2016-05-05       Impact factor: 53.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.